keyword
https://read.qxmd.com/read/32808006/management-of-thrombotic-microangiopathy-in-pregnancy-and-postpartum-report-from-an-international-working-group
#21
JOURNAL ARTICLE
Fadi Fakhouri, Marie Scully, François Provôt, Miquel Blasco, Paul Coppo, Marina Noris, Kathy Paizis, David Kavanagh, Frédéric Pène, Sol Quezada, Alexandre Hertig, Sébastien Kissling, Patrick O'Brien, Yahsou Delmas, Lorenzo Alberio, Norbert Winer, Agnès Veyradier, Spero Cataland, Véronique Frémeaux-Bacchi, Chantal Loirat, Giuseppe Remuzzi, Vassilis Tsatsaris
Pregnancy and postpartum are high-risk periods for different forms of thrombotic microangiopathy (TMA). However, the management of pregnancy-associated TMA remains ill defined. This report, by an international multidisciplinary working group of obstetricians, nephrologists, hematologists, intensivists, neonatologists, and complement biologists, summarizes the current knowledge of these potentially severe disorders and proposes a practical clinical approach to diagnose and manage an episode of pregnancy-associated TMA...
November 5, 2020: Blood
https://read.qxmd.com/read/32571673/comparison-of-abo-antibody-levels-in-apheresis-platelets-suspended-in-platelet-additive-solution-and-plasma
#22
JOURNAL ARTICLE
Gayathiri Kc, Mohandoss Murugesan, Sangeetha K Nayanar, Riyas Malodan, Maya Padmanaban
BACKGROUND: Transfusion of platelets (PLTs) with high ABO antibody titres can pose a risk of hemolysis if the unit crosses the ABO type. The PLTs stored in the platelet additive solution (PAS) remove asubstantial fraction of plasma and replace it with an isotonicbuffered solution.We aimed to assess the difference in anti-A/B antibody levels in Groups O, A and B apheresis platelets (APs) suspended in plasma and PAS. METHODOLOGY: Apheresis donors are categorized into two groups, Plasma (Group I) and PAS (Group II), each blood group (A, B and O) had 20 samples...
June 15, 2020: Hematology, Transfusion and Cell Therapy
https://read.qxmd.com/read/32553248/complement-mediated-disorders-in-pregnancy
#23
REVIEW
Kana Amari Chinchilla, Madhusudan Vijayan, Bruna Taveras Garcia, Belinda Jim
Complement-mediated disorders in pregnancy span a large spectrum and have been implicated in all three complement pathways: classical, lectin, and alternative. Our understanding of these disorders in recent years has advanced due to a better understanding of complement regulatory proteins, such as complement factor H, complement factor I, membrane cofactor protein, and thrombomodulin that particularly affect the alternative complement pathway. Enthusiasm in genotyping for mutations that encode these proteins has allowed us to study the presence of genetic variants which may predispose women to develop conditions such as pregnancy-associated hemolytic uremic syndrome (P-aHUS), thrombotic thrombocytopenic purpura, preeclampsia/hemolysis, elevated liver enzymes, low platelets (HELLP), systemic lupus erythematosus/antiphospholipid syndrome, and peripartum cardiomyopathy...
March 2020: Advances in Chronic Kidney Disease
https://read.qxmd.com/read/32477291/biofungicidal-potential-of-neosartorya-aspergillus-fischeri-antifungal-protein-nfap-and-novel-synthetic-%C3%AE-core-peptides
#24
JOURNAL ARTICLE
Liliána Tóth, Györgyi Váradi, Éva Boros, Attila Borics, Hargita Ficze, István Nagy, Gábor K Tóth, Gábor Rákhely, Florentine Marx, László Galgóczy
Because of enormous crop losses worldwide due to pesticide-resistant plant pathogenic fungi, there is an increasing demand for the development of novel antifungal strategies in agriculture. Antifungal proteins (APs) and peptides are considered potential biofungicides; however, several factors limit their direct agricultural application, such as the high cost of production, narrow antifungal spectrum, and detrimental effects to plant development and human/animal health. This study evaluated the safety of the application of APs and peptides from the ascomycete Neosartorya fischeri as crop preservatives...
2020: Frontiers in Microbiology
https://read.qxmd.com/read/32224689/the-application-of-rotem-in-a-parturient-with-antiphospholipid-syndrome-in-the-setting-of-anticoagulation-for-cesarean-delivery-a-case-report
#25
JOURNAL ARTICLE
Antonio Gonzalez Fiol, Kristen L Fardelmann, Patsy J McGuire, Audrey A Merriam, Alex Miller, Aymen Alian
A 35-year-old parturient with antiphospholipid syndrome and a working diagnosis of hemolysis, elevated liver enzyme, and low platelets (HELLP) underwent a cesarean delivery 9 hours after receiving heparin. Her preoperative activated partial thromboplastin time and rotational thromboelastometry (ROTEM) intrinsic pathway (INTEM) clotting time were 120 and 1870 seconds, respectively. Fresh frozen plasma was administered for heparin neutralization. The ROTEM INTEM/heparinase assay (HEPTEM) ratio can help confirm heparin neutralization and guide intraoperative transfusion management...
April 2020: A&A Practice
https://read.qxmd.com/read/32187355/fcrn-augments-induction-of-tissue-factor-activity-by-igg-containing-immune-complexes
#26
JOURNAL ARTICLE
Douglas B Cines, Sergei Zaitsev, Lubica Rauova, Ann H Rux, Victoria Stepanova, Sriram Krishnaswamy, Amrita Sarkar, M Anna Kowalska, Guohua Zhao, Alan E Mast, Laurence J Blumberg, Keith R McCrae, Mortimer Poncz, Jonathan J Hubbard, Michal Pyzik, Richard S Blumberg
Thromboembolism complicates disorders caused by immunoglobulin G (IgG)-containing immune complexes (ICs), but the underlying mechanisms are incompletely understood. Prior evidence indicates that induction of tissue factor (TF) on monocytes, a pivotal step in the initiation, localization, and propagation of coagulation by ICs, is mediated through Fcγ receptor IIa (FcγRIIa); however, the involvement of other receptors has not been investigated in detail. The neonatal Fc receptor (FcRn) that mediates IgG and albumin recycling also participates in cellular responses to IgG-containing ICs...
June 4, 2020: Blood
https://read.qxmd.com/read/31757523/thrombocytopenia-in-pregnancy-diagnosis-and-approach-to-management
#27
REVIEW
Allyson M Pishko, Lisa D Levine, Douglas B Cines
Thrombocytopenia during pregnancy presents unique challenges for the hematologist. Obstetricians generally manage many of the pregnancy-specific etiologies, ranging from the benign (gestational thrombocytopenia) to the life-threatening (preeclampsia; hemolysis, elevated liver enzymes and low platelets syndrome; and acute fatty liver of pregnancy). However, hematologists may be consulted for atypical and severe presentations and to help manage non-pregnancy specific etiologies, including immune thrombocytopenia, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome and antiphospholipid syndrome, among others, in which maternal and fetal risks must be considered...
March 2020: Blood Reviews
https://read.qxmd.com/read/30837214/high-risk-of-adverse-pregnancy-outcomes-in-women-with-a-persistent-lupus-anticoagulant
#28
JOURNAL ARTICLE
Johanna Gebhart, Florian Posch, Silvia Koder, Peter Quehenberger, Thomas Perkmann, Lorenz Kuessel, Cihan Ay, Ingrid Pabinger
Lupus anticoagulant (LA) has been associated with pregnancy complications and pregnancy loss. Identification of predictive factors could aid in deciding on therapeutic management. To identify risk factors for adverse pregnancy outcomes in high-risk women with persistently positive LA, we prospectively followed 82 women of childbearing age, of whom 23 had 40 pregnancies within the Vienna Lupus Anticoagulant and Thrombosis Study. Pregnancy complications occurred in 28/40 (70%) pregnancies, including 22 (55%) spontaneous abortions (<10th week of gestation [WOG]: n = 12, 10th to 24th WOG: n = 10) and 6 deliveries <34th WOG (15%, 3 due to severe preeclampsia/HELLP [hemolysis, elevated liver enzymes, and a low platelet count] syndrome, 3 due to placental insufficiency)...
March 12, 2019: Blood Advances
https://read.qxmd.com/read/30400982/intrauterine-fetal-deaths-related-to-antiphospholipid-syndrome-a-descriptive-study-of-65-women
#29
MULTICENTER STUDY
Mériem Belhocine, Laetitia Coutte, Nicolas Martin Silva, Nathalie Morel, Gaëlle Guettrot-Imbert, Romain Paule, Claire Le Jeunne, Micaela Fredi, Michel Dreyfus, Jean-Charles Piette, Odile Souchaud-Debouverie, Catherine Deneux-Tharaux, Vassilis Tsatsaris, Emmanuelle Pannier, Véronique Le Guern, Nathalie Costedoat-Chalumeau
OBJECTIVE: Although one of the three obstetric manifestations of antiphospholipid syndrome (APS) is intrauterine fetal death (IUFD), little is known about it in this context. We report the first large series of patients with APS and IUFD. METHODS: We retrospectively analyzed the history and clinical data of women at four French hospitals. All had (1) APS diagnosis (Sydney criteria) and (2) IUFD at or after 10 weeks of gestation (weeks) between 2000 and 2016...
November 6, 2018: Arthritis Research & Therapy
https://read.qxmd.com/read/30290624/eculizumab-in-a-pregnant-patient-with-laboratory-onset-of-catastrophic-antiphospholipid-syndrome-a-case-report
#30
JOURNAL ARTICLE
Patrizia Rovere-Querini, Valentina Canti, Roberta Erra, Esperia Bianchi, Giorgio Slaviero, Armando D'Angelo, Susanna Rosa, Massimo Candiani, Maria Teresa Castiglioni
RATIONALE: Hypercoagulability and pregnancy morbidity are hallmarks of the antiphospholipid syndrome (APS). Catastrophic antiphospholipid syndrome (CAPS) is a potentially life-threatening omplication of APS, with widespread acute thrombotic microangiopathy (TMA) that can be precipitated by pregnancy and delivery and result in multiorgan damage. Unrestrained activation of the complement cascade is involved, favoring endothelial activation, tissue factor expression by leukocytes, and platelet aggregation...
October 2018: Medicine (Baltimore)
https://read.qxmd.com/read/29961692/maternal-and-fetal-outcomes-in-a-cohort-of-patients-exposed-to-tumor-necrosis-factor-inhibitors-throughout-pregnancy
#31
JOURNAL ARTICLE
Geneviève Genest, Karen A Spitzer, Carl A Laskin
OBJECTIVE: Tumor necrosis factor inhibitors (TNFi) are increasingly used in pregnancy but are frequently withheld in the second or third trimesters. We evaluated the maternal and fetal outcomes of women who continued their TNFi throughout pregnancy compared to women who interrupted TNFi during pregnancy. METHODS: We retrospectively analyzed the outcomes of women seen in clinic with rheumatoid arthritis (RA), psoriatic arthritis, juvenile idiopathic arthritis (JIA), or ankylosing spondylitis, who were exposed to TNFi during pregnancy...
August 2018: Journal of Rheumatology
https://read.qxmd.com/read/29808136/clinical-report-of-probable-catastrophic-antiphospholipid-syndrome-in-pregnancy
#32
Eryk Hakman, Sasha Mikhael
Background: Catastrophic APS (CAPS) is a rare but life-threatening form of APS defined as multiorgan thrombosis affecting a minimum of three organs with confirmation by histopathology of small vessel occlusions in at least one organ or tissue. The development of CAPS in pregnancy poses many diagnostic challenges as a result of its broad range of clinical presentations and its overlap with other obstetric complications and microangiopathic diseases. Because of the high associated mortality rate, prompt recognition and treatment are paramount...
2018: Case Reports in Obstetrics and Gynecology
https://read.qxmd.com/read/29557617/anticardiolipin-antibodies-in-concurrent-poststreptococcal-glomerulonephritis-and-autoimmune-hemolytic-anemia-a-case-report
#33
JOURNAL ARTICLE
Ying-Liang Gong, Yu-Feng Li
We present a case of acute post-streptococcal glomerulonephritis (APSGN) with autoimmune hemolytic anemia (AIHA). Along with the classic findings of APSGN, the patient had a positive direct antiglobulin test and an anticardiolipin antibody without any typical clinical manifestations of antiphospholipid syndrome (APS). This case raises questions of the relationship between Streptococcus and the development of autoimmune hemolytic anemia in children. Our case highlights the possibility that the streptococcal infections in this patient might be responsible for her anemia, either in setting of underlying antiphospholipid antibodies, or in having triggered the development of pathogenic antibodies, which subsequently leads to the clinical evolution of hemolysis...
April 1, 2018: Archivos Argentinos de Pediatría
https://read.qxmd.com/read/29413946/trichomonas-vaginalis-cathepsin-d-like-aspartic-proteinase-tv-catd-is-positively-regulated-by-glucose-and-degrades-human-hemoglobin
#34
JOURNAL ARTICLE
Maria Inocente Mancilla-Olea, Jaime Ortega-López, Elisa E Figueroa-Angulo, Leticia Avila-González, Rosa Elena Cárdenas-Guerra, Jesús F T Miranda-Ozuna, Arturo González-Robles, Mar Saraí Hernández-García, Lizbeth Sánchez-Ayala, Rossana Arroyo
Trichomonas vaginalis genome encodes ∼440 proteases, six of which are aspartic proteases (APs). However, only one belongs to a clan AA (EC 3.4.23.5), family A1 (pepsin A), cathepsin D-like protease. This AP is encoded by an 1113-bp gene (tv-catd), which translates into a 370-aa residues zymogen of 40.7-kDa and a theoretical pI of 4.6, generating a ∼35 kDa active enzyme after maturation (Tv-CatD). The goal of this study was to identify and analyze the effect of glucose on the expression of Tv-CatD at the transcript and protein levels, subcellular localization, and proteolytic activity...
April 2018: International Journal of Biochemistry & Cell Biology
https://read.qxmd.com/read/27991616/atb-0-transporter-mediated-targeting-delivery-to-human-lung-cancer-cells-via-aspartate-modified-docetaxel-loading-stealth-liposomes
#35
JOURNAL ARTICLE
Qiuhua Luo, Bin Yang, Wenhui Tao, Jia Li, Longfa Kou, He Lian, Xin Che, Zhonggui He, Jin Sun
Tumor cells have an increased demand for amino acids to support their rapid growth and malignant metastasis. Transfer of amino acids across plasma membranes depends on several amino acid transporters that are highly upregulated in tumor cells and are promising targets for tumor cell-selective therapy. In this study, stealth liposomal systems functionalized with aspartate-polyoxyethylene stearate conjugate (APS) were developed for transporter-mediated targeted delivery to ATB0,+ , which is overexpressed human lung cells...
January 31, 2017: Biomaterials Science
https://read.qxmd.com/read/27927881/brain-abscess-due-to-listeria-monocytogenes-after-hellp-syndrome-in-a-patient-with-antiphospholipid-syndrome
#36
JOURNAL ARTICLE
A Fervienza, M Bodro, P Castro, S Hernández, I Teixidó, G Espinosa, R Cervera
Objective To illustrate an unusual case of Listeria cerebral abscess. Material and methods A 32-year-old pregnant woman with thrombotic antiphospholipid syndrome (APS) received corticotherapy for two weeks due to hemolysis, elevated liver enzymes, low platelet (HELLP) syndrome. After delivery she presented with neurological symptoms and fever. Results The MRI scan confirmed the presence of a brain abscess, and Listeria monocytogenes was isolated in blood cultures. After eight weeks of antibiotic treatment, the patient presented no sequelae...
August 2017: Lupus
https://read.qxmd.com/read/27578899/bentall-surgery-in-a-patient-with-cold-agglutinin-and-antiphospholipid-antibody-double-trouble
#37
JOURNAL ARTICLE
Monish S Raut, Gulshan Rohra, Ganesh Shivnani, Arun Maheshwari, Sumir Dubey, Rajpal Singh Bhathiwal, Deevakar Sharma
Cold agglutinin disease is an uncommon disease with potential to cause hemolysis and thrombosis during hypothermic cardiac surgery. Antiphospholipid syndrome is also rare disease with hypercoagulation tendacy. Perioperative management of both these diseases is challenging. We present successful perioperative management of high risk Bentall surgery in patient with both these dreadful diseases.
June 2016: Journal of Extra-corporeal Technology
https://read.qxmd.com/read/27116985/-variation-of-long-chain-3-hydroxyacyl-coa-dehydrogenase-dna-methylated-modification-and-correlation-with-gene-mrna-expression-of-early-onset-preeclampsia-hellp-syndrome-and-antiphospholipid-syndrome-in-trophoblast-cells-of-placenta
#38
JOURNAL ARTICLE
R Meng, Z Yang, H L Wang, Y W Han, Y L Wang, H Yu
OBJECTIVE: By detecting the DNA methylation and gene expression of long-chain 3-hydroxyacyl CoA dehydrogenase(LCHAD)in trophoblast cells, analyze the correlation of DNA methylation and gene expression in early-onset preeclampsia(EPE), hemolysis, elevated liver enzymes, and low platelets(HELLP)syndrome and antiphospholipid syndrome(APS), to investigate the molecular basis of long-chain fatty acid oxidation changes in different preeclampsia and pathological pregnancy. METHODS: Primary human cytotrophoblast cells and HTR8/Svneo cells were treated with serum from patients with EPE(14 cases), HELLP(12 cases), APS(14 cases), and normal pregnant women(NP, 14 cases)...
April 25, 2016: Zhonghua Fu Chan Ke za Zhi
https://read.qxmd.com/read/27023104/catastrophic-antiphospholipid-syndrome-in-pregnancy-a-diagnosis-that-should-not-be-missed
#39
REVIEW
Jennifer G Hoayek, Hind N Moussa, Hina A Rehman, Susan Hosseini Nasab, Sean C Blackwell, Baha M Sibai
Catastrophic antiphospholipid syndrome (CAPS) is an accelerated form of the antiphospholipid antibody syndrome resulting in multi-organ ischemia and failure. It is a rare and life-threatening condition that can be easily mistaken with hemolysis elevated liver enzymes low platelets syndrome, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. In order to make a diagnosis, it is required to have multi-organ thrombosis over 1 week affecting at least three organs or systems, and to have positive antiphospholipid antibody on two occasions (6 weeks apart), and histopathologic confirmation of small vessel occlusion...
December 2016: Journal of Maternal-fetal & Neonatal Medicine
https://read.qxmd.com/read/27022879/ald-mediated-heparin-grafting-on-nitinol-for-self-expanded-carotid-stents
#40
JOURNAL ARTICLE
Fei Wang, Yan Zhang, Xiumian Chen, Bing Leng, Xin Guo, Tao Zhang
Carotid-artery atherosclerosis is a common cause of ischemic stroke. Carotid-artery stenting (CAS) is one of the most effective treatments. However, In-stent restenosis (ISR) and re-endothelialization delay are two major issues of intravascular stent which affect clinical safety and reduce effects. In this study, atomic layer deposition (ALD) technology was applied to deposit a layer (10nm) of Al2O3 on Nitinol surface as an intermediate functional layer. The alumina covered surface was then modified with a coupling agent 3-aminopropyltriethoxysilane (APS) and heparin sequentially in order to improve the hemocompatibility of Nitinol stents...
July 1, 2016: Colloids and Surfaces. B, Biointerfaces
keyword
keyword
9018
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.